Stock data
Astellas Pharma$10.07
4503 
0.35% • 24 H
0.35% • 24 HDividend Yield:3.5%
Global Rank#938
Market Cap$18.33B
YTD Performance-7.84%
P/E0.19
Revenue$9.67B
Change 7d1.15%
SP500 BenchmarkUnderperform
Country🇯🇵 Japan
P/S1.90
Earnings$628.57M
Dividend Yield:3.5%
Main Sector
Healthcare
Astellas Pharma Revenue data
According to Astellas Pharma latest financial reports the company had revenue of $9.67B in 2023-03-31, a 17.16% increase from 2022. Astellas Pharma highest revenue was $9.67B in 2023.
Revenue history for Astellas Pharma from 2020 to 2024
-
Value:-
Astellas Pharma revenue by year
| Year | Revenue | Change |
|---|---|---|
| 2023 | $9.67B | 17.16% |
| 2022 | $8.25B | 3.73% |
| 2021 | $7.96B | -3.94% |
| 2020 | $8.28B | - |
View the top revenue stocks 
